Cochrane · systematic review · CD011888

Aspirin for acute treatment of episodic tension‐type headache in adults

Derry, S, Wiffen, PJ, Moore, RA · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
8
current version
GRADE rated
8
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 6 · 75%Low 2 · 25%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Aspirin 1000 mg compared with placebo for episodic tension‐type headache

Population: adults with episodic tension‐type headache
8 questions
OutcomeEffectEvidenceStatus / GRADE
Pain‐free at 2 hours
Aspirin 1000 mg vs placebo
no estimate extractedNRVery low
Pain‐free at other time points (1, 4, 24 hours)
Aspirin 1000 mg vs placebo
no estimate extractedNRVery low
Pain‐free or mild pain at 2 hours
Aspirin 1000 mg vs placebo
no estimate extracted1 study · 215 participantsVery low
Use of rescue medication
Aspirin 1000 mg vs placebo
no estimate extracted2 studies · 397 participantsLow
Patient Global Evaluation at end of study
Aspirin 1000 mg vs placebo
no estimate extracted2 studies · 397 participantsVery low
Any adverse event
Aspirin 1000 mg vs placebo
no estimate extracted3 studies · 723 participantsLow
Specific adverse events
Aspirin 1000 mg vs placebo
no estimate extracted4 studies · 767 participantsVery low
Serious adverse events
Aspirin 1000 mg vs placebo
no estimate extracted4 studies · 767 participantsVery low